mk 0663 has been researched along with Hemophilia A in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cavanaugh, PF; Matsumoto, AK | 1 |
Curtis, SP; Eyster, ME; Giallella, KM; Melian, A; Mukhopadhyay, S; Reicin, AS; Shingo, S; Tsoukas, C | 1 |
1 review(s) available for mk 0663 and Hemophilia A
Article | Year |
---|---|
Etoricoxib.
Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones | 2004 |
1 trial(s) available for mk 0663 and Hemophilia A
Article | Year |
---|---|
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.
Topics: Adolescent; Adult; Aged; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Headache; Hemarthrosis; Hemophilia A; Humans; Lactones; Male; Membrane Proteins; Middle Aged; Pyridines; Respiratory Tract Infections; Sulfones; Treatment Outcome | 2006 |